
(AGENPARL) – NEW HAVEN, CONNECTICUT (USA) sab 15 aprile 2023 A Yale-led clinical trial found that the medicine ritlecitinib appears safe and promising for treating adolescents with a form of often-disfiguring hair loss.
Fonte/Source: https://news.yale.edu/2023/04/13/progress-search-alopecia-areata-treatment-adolescents